These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 37912644)

  • 21. Antihypertensive effect of amlodipine compared with nifedipine retard in patients with mild and moderate essential hypertension.
    Kalina Z; Okopień B; Madej A; Tokarz D; Maślankiewicz A; Szwed Z; Gross-Furek V; Herman ZS
    Boll Chim Farm; 1998; 137(7):281-5. PubMed ID: 9795483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic effects of long-term treatments with nifedipine-retard and captopril in young hypertensive patients.
    Masuo K; Mikami H; Ogihara T; Tuck ML
    Am J Hypertens; 1997 Jun; 10(6):600-10. PubMed ID: 9194505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the efficacy of two different modified release methylphenidate preparations for children and adolescents with attention-deficit/hyperactivity disorder in a natural setting: comparison of the efficacy of Medikinet(®) retard and Concerta(®)--a randomized, controlled, double-blind multicenter clinical crossover trial.
    Döpfner M; Ose C; Fischer R; Ammer R; Scherag A
    J Child Adolesc Psychopharmacol; 2011 Oct; 21(5):445-54. PubMed ID: 21790298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of captopril and nifedipine in black and white patients with hypertensive crisis.
    Damasceno A; Ferreira B; Patel S; Sevene E; Polónia J
    J Hum Hypertens; 1997 Aug; 11(8):471-6. PubMed ID: 9322826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trough:peak ratio of nifedipine gastrointestinal therapeutic system and nifedipine retard in essential hypertensive patients: an Italian multicentre study.
    Salvetti A; Virdis A; Taddei S; Ambrosoli S; Caiazza A; Gandolfi E; del Prato C; Saba G; nello Ceccarelli C; Buoninconti R; Spadari G; Kilama MO
    J Hypertens; 1996 May; 14(5):661-7. PubMed ID: 8762211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential pharmacobezoar formation of large size extended-release tablets and their dissolution - an in vitro study.
    Hoegberg LCG; Refsgaard F; Pedersen SH; Personne M; Ullah S; Panagiotidis G; Petersen TS; Annas A
    Clin Toxicol (Phila); 2019 Apr; 57(4):271-281. PubMed ID: 30306811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of bioequivalence between two methylphenidate extended modified release formulations in healthy volunteers.
    Schütz H; Fischer R; Grossmann M; Mazur D; Leis HJ; Ammer R
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):761-9. PubMed ID: 19954715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerability of nicardipine retard and captopril in hypertension in the aged. Results of a multicenter study].
    Mancia G; Buoninconti R; Errico M; Freda M; Giordano MP; Granata Q; Lucentini ML; Marsili P; Pasotti C; Piccolo E
    Minerva Med; 1992 Nov; 83(11):731-8. PubMed ID: 1461544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nifedipine-retard versus nifedipine-capsules for the therapy of hypertensive crisis in black patients.
    Damasceno A; Sevene E; Patel S; Polónia J
    J Cardiovasc Pharmacol; 1998 Jan; 31(1):165-9. PubMed ID: 9456291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analgesic and muscle tonus normalizing effect of flupirtine retard in chronic back pain. Results of a standardized therapeutic evaluation applying objective methods for measuring pain pressure threshold, pain pressure tolerance and muscle tension].
    Müller-Schwefe GH; Uberall MA
    MMW Fortschr Med; 2008 Jan; 149 Suppl 4():153-61. PubMed ID: 18402240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure reduction and tolerability of amlodipine versus nifedipine retard in Chinese patients with type 2 diabetes mellitus and hypertension: a randomized 1-year clinical trial.
    Ko GT; Chan HC; Chan CH
    Int J Clin Pharmacol Ther; 2001 Aug; 39(8):331-5. PubMed ID: 11515707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of nifedipine retard with angiotensin converting enzyme inhibitors in Japanese hypertensive patients with coronary artery disease: the Japan Multicenter Investigation for Cardiovascular Diseases-B (JMIC-B) randomized trial.
    Yui Y; Sumiyoshi T; Kodama K; Hirayama A; Nonogi H; Kanmatsuse K; Origasa H; Iimura O; Ishii M; Saruta T; Arakawa K; Hosoda S; Kawai C;
    Hypertens Res; 2004 Mar; 27(3):181-91. PubMed ID: 15080377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers.
    Popović J; Mitić R; Sabo A; Mikov M; Jakovljević V; Daković-Svajcer K
    Eur J Drug Metab Pharmacokinet; 2006; 31(2):87-96. PubMed ID: 16898076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endoscopic evaluation of a retard cimetidine preparation with reference to its effect in stomach and duodenal ulcer. A comparative study with a non-retard cimetidine preparation].
    Tscheliessnigg KH; Berger A; Mischinger HJ; Kraft-Kinz J
    Wien Med Wochenschr; 1987 Aug; 137(14-15):350-5. PubMed ID: 3314173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selecting a Bachelor of Dental Science Degree in Dental Hygiene: Stories shared from a narrative inquiry.
    Kanji Z; Pidgeon M; Nilson M
    J Dent Hyg; 2019 Aug; 93(4):44-52. PubMed ID: 31409723
    [No Abstract]   [Full Text] [Related]  

  • 36. The Cholera, and the Influences Which Favor and Retard Its Spread or Diffusion.
    Davis NS
    Northwest Med Surg J; 1850 Mar; 2(6):482-497. PubMed ID: 37319602
    [No Abstract]   [Full Text] [Related]  

  • 37. STATINS TREATMENT AND ORO-DENTAL ASPECTS IN A CASE OF HEREDITARY HYPERCHOLESTEROLEMIA IN A CHILD UNDER 6 YEARS.
    Constantin AT; Covacescu SM; Kozma A; Gherghina I; Lazarescu H
    Acta Endocrinol (Buchar); 2019; 15(3):378-383. PubMed ID: 32010359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cause Which Retard Dental Progress.
    Dent Regist; 1861 Nov; 15(11):613-616. PubMed ID: 33694825
    [No Abstract]   [Full Text] [Related]  

  • 39. Conditions Which Promote or Retard the Progress of Dental Caries.
    Peirce CN
    Int Dent J (Phila); 1889 Jun; 10(6):329-336. PubMed ID: 37910946
    [No Abstract]   [Full Text] [Related]  

  • 40. Bacterial lysine decarboxylase influences human dental biofilm lysine content, biofilm accumulation, and subclinical gingival inflammation.
    Lohinai Z; Keremi B; Szoko E; Tabi T; Szabo C; Tulassay Z; Levine M
    J Periodontol; 2012 Aug; 83(8):1048-56. PubMed ID: 22141361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.